Walleye Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Walleye Capital’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-266,782	Closed	-$451K	–	4533
2022 Q4	$451K	Buy	+266,782	New	+$338K	0.01%	1519
2021 Q4	–	Sell	-17,772	Closed	-$177	–	2407
2021 Q3	$177	Sell	17,772 -661	-4%	-$6.57K	0.01%	1220
2021 Q2	$184	Hold	18,433	–	–	0.01%	1075
2021 Q1	$184	Buy	+18,433	New	+$191K	0.01%	940

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Walleye Capital's PRDS Position: Q1 2023 in Review

Walleye Capital sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q1 2023, closing a stake of 266,782 shares — an estimated $451K sold.

Walleye Capital first reported a position in PRDS in Q1 2021 and held it in 4 quarters. The position peaked at $451K in Q4 2022. 61 funds tracked by Wall St. Rank hold PRDS as of Q1 2023.

Walleye Capital reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 266,782 Pardes Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $451K.
Walleye Capital first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Walleye Capital's Pardes Biosciences, Inc. Common Stock position peaked at $451K in Q4 2022.
61 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.